1
|
Hughes AC, Kirkland M, Du W, Rasooly R, Hernlem B, Tam C, Zhang Y, He X. Development of Thermally Stable Nanobodies for Detection and Neutralization of Staphylococcal Enterotoxin B. Toxins (Basel) 2023; 15:400. [PMID: 37368700 DOI: 10.3390/toxins15060400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2023] [Revised: 06/02/2023] [Accepted: 06/14/2023] [Indexed: 06/29/2023] Open
Abstract
In this study, sixteen unique staphylococcal enterotoxin B (SEB)-reactive nanobodies (nbs), including ten monovalent and six bivalent nbs, were developed. All characterized nbs were highly specific for SEB and did not cross-react with other staphylococcal enterotoxins (SE). Several formats of highly sensitive enzyme-linked immunosorbent assays (ELISAs) were established using SEB nbs and a polyclonal antibody (pAb). The lowest limit of detection (LOD) reached 50 pg/mL in PBS. When applied to an ELISA to detect SEB-spiked milk (a commonly contaminated foodstuff), a LOD as low as 190 pg/mL was obtained. The sensitivity of ELISA was found to increase concurrently with the valency of nbs used in the assay. In addition, a wide range of thermal tolerance was observed among the sixteen nbs, with a subset of nbs, SEB-5, SEB-9, and SEB-62, retaining activity even after exposure to 95 °C for 10 min, whereas the conventional monoclonal and polyclonal antibodies exhibited heat-labile properties. Several nbs demonstrated a long shelf-life, with one nb (SEB-9) retaining 93% of its activity after two weeks of storage at room temperature. In addition to their usage in toxin detection, eleven out of fifteen nbs were capable of neutralizing SEB's super-antigenic activity, demonstrated by their inhibition on IL-2 expression in an ex vivo human PBMC assay. Compared to monoclonal and polyclonal antibodies, the nbs are relatively small, thermally stable, and easy to produce, making them useful in applications for sensitive, specific, and cost-effective detection and management of SEB contamination in food products.
Collapse
Affiliation(s)
- Anna C Hughes
- Western Regional Research Center United States Department of Agriculture, Agricultural Research Service, 800 Buchanan St., Albany, CA 94710, USA
| | - Marina Kirkland
- Western Regional Research Center United States Department of Agriculture, Agricultural Research Service, 800 Buchanan St., Albany, CA 94710, USA
| | - Wenxian Du
- Western Regional Research Center United States Department of Agriculture, Agricultural Research Service, 800 Buchanan St., Albany, CA 94710, USA
| | - Reuven Rasooly
- Western Regional Research Center United States Department of Agriculture, Agricultural Research Service, 800 Buchanan St., Albany, CA 94710, USA
| | - Bradley Hernlem
- Western Regional Research Center United States Department of Agriculture, Agricultural Research Service, 800 Buchanan St., Albany, CA 94710, USA
| | - Christina Tam
- Western Regional Research Center United States Department of Agriculture, Agricultural Research Service, 800 Buchanan St., Albany, CA 94710, USA
| | - Yuzhu Zhang
- Western Regional Research Center United States Department of Agriculture, Agricultural Research Service, 800 Buchanan St., Albany, CA 94710, USA
| | - Xiaohua He
- Western Regional Research Center United States Department of Agriculture, Agricultural Research Service, 800 Buchanan St., Albany, CA 94710, USA
| |
Collapse
|
2
|
Tam C, Zhao FL, Gauba R, Kouhkamari M, Li S, Tang B. 204MO Patterns of treatment and outcomes in CLL patients in Australia: An analysis of the population-wide pharmaceutical benefits scheme dataset. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022] Open
|
3
|
Tam C, Zhao FL, Gauba R, Azam S, Li S, Tang B. 205MO Patterns of treatment and outcomes in MCL patients in Australia: An analysis of the population-wide pharmaceutical benefits scheme dataset. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/05/2022] Open
|
4
|
Estem K, Tam C, Lengyel K, Rorden E, Polonchak J, Dorosan E, Crane C, Emanuel B, Bulic S, Nguyen P, Winfrey E, Gonzalez E, Carpenter S, Nanda N, Kim-tenser MA. Abstract TP85: A Collaborative Approach In The Reduction Of Hospital Acquired Infections In A Neuroscience ICU. Stroke 2022. [DOI: 10.1161/str.53.suppl_1.tp85] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Intro:
HAIs such as catheter associated urinary tract infections (CAUTIs) and central line associated bloodstream infections (CLABSIs) increase morbidity, mortality, healthcare cost, and account for a significant burden of patient harm. We describe efforts between nursing, Infection Prevention (IP), and clinicians in the reduction of HAI-CAUTIs and HAI-CLABSIs on a neuroscience intensive care unit (NeuroICU) in an academic acute care hospital.
Methods:
Using the Centers for Disease Control and Prevention’s (CDC) Targeted Assessment for Prevention (TAP) framework [Target, Assess, Prevent], IP identified the Neuro-ICU as having an excess burden of HAI-CAUTIs and HAI-CLABSIs and facilitated interdisciplinary engagement. In partnership, nursing, IP, and Neuro-ICU clinicians, developed action plans focused on foley catheter (FC) and central line (CL) utilization, FC bundle compliance, FC maintenance competency validation, and training on central line maintenance. Monthly meetings to discuss progress and identify barriers were performed. Neuro-ICU clinicians and nurse managers performed device rounds twice a day to discuss device necessity utilizing a nurse-driven protocol, and verified FC and CL removal. This project used the CDC’s National Healthcare Safety Network (NHSN) healthcare-associated infection (HAI) tracking system to compute standardized infection ratios, HAI events, FC utilization, and CL utilization. CLABSI and CAUTI bundle compliance were evaluated using an electronic audit tool. Staff competency validation and education attendance were tracked. The project period was from September 2020-July 2021 for CAUTI and January 2021-July 2021 for CLABSI.
Results:
HAI-CAUTI events decreased from 6 to 1, the standardized infection ratio (SIR) reduced from 3.003 to 0.593, and the FC utilization ratio decreased from 0.36 to 0.31 from October 2019- August 2020 to September 2020-July 2021. HAI-CLABSI events decreased from 1 to 0, CL utilization ratio decreased from 3.31 to 2.81 from June 2020- December 2020 to January 2021- July 2021.
Conclusions:
These results suggest that an interdisciplinary approach and robust IP practices may be an effective approach to improving patient safety and reducing patient harm.
Collapse
Affiliation(s)
| | - Christina Tam
- Infection Prevention, Univ of Southern California, Los Angeles, CA
| | | | | | | | | | | | | | | | | | | | | | | | - Neha Nanda
- Univ of Southern California, Los Angeles, CA
| | | |
Collapse
|
5
|
Rye E, Tam C, Nguyen H, Farrell M, McNatty D, Brookes M, Morris J, Sindone A, Tofler G. HEart Failure Dashboard Project (HEFD): An Innovative eMR Based Quality Improvement Project. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
6
|
Chen L, Yokoyama W, Tam C, Tan Y, Alves P, Bartley G, Zhong F. Evaluation of Cellular Absorption and Metabolism of β-Carotene Loaded in Nanocarriers after In Vitro Digestion. J Agric Food Chem 2021; 69:9383-9394. [PMID: 34347475 DOI: 10.1021/acs.jafc.1c02431] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Three protein emulsifiers encapsulating β-carotene (BC) with accompanying lipids into nanoemulsions (NEs) or without lipids into nanoparticles (NPs) were fabricated to study the effect of the type of interfacial protein on carrier design and the structure remodeling during digestion on the overall uptake and metabolism of BC in Caco-2 cells. BC-loaded micelles and micellar-like aggregates were collected after in vitro digestion and applied to Caco-2 cell monolayers. The digestion process significantly enhanced the cellular uptake of BC by 1.2-2.2 times and 4.1-8.2 times loaded in NEs and NPs, respectively. Whey protein isolate-based carriers improved the absorption but decreased the metabolism of BC to retinyl palmitate. The presence of lipids was found to improve metabolism and aid the transport of retinoids to the basolateral side of Caco-2 monolayers. Understanding the transportation behavior of the protein-based nanocarries after digestion may contribute to the design of biosafe carriers with higher bioavailability to deliver lipophilic nutrients.
Collapse
Affiliation(s)
- Ling Chen
- Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, Jiangnan University, Wuxi 214122, China
- School of Food Science and Technology, Jiangnan University, Wuxi 214122, China
| | - Wallace Yokoyama
- Western Regional Research Center, ARS, USDA, Albany, California 94710, United States
| | - Christina Tam
- Western Regional Research Center, ARS, USDA, Albany, California 94710, United States
| | - Yuqing Tan
- Beijing Laboratory for Food Quality and Safety, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China
| | - Pricilla Alves
- Western Regional Research Center, ARS, USDA, Albany, California 94710, United States
| | - Glenn Bartley
- Western Regional Research Center, ARS, USDA, Albany, California 94710, United States
| | - Fang Zhong
- Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, Jiangnan University, Wuxi 214122, China
- School of Food Science and Technology, Jiangnan University, Wuxi 214122, China
| |
Collapse
|
7
|
Jurczak W, Tam C, Eckert K, Lin J, Neuenburg JK, Wang ML. FIRST‐LINE IBRUTINIB + VENETOCLAX TREATMENT FOR MANTLE CELL LYMPHOMA IN OLDER PATIENTS OR THOSE WITH
TP53
MUTATION: A NEW OPEN‐LABEL ARM OF THE PHASE 3 PCYC‐1143 SYMPATICO STUDY. Hematol Oncol 2021. [DOI: 10.1002/hon.172_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- W. Jurczak
- Maria Sklodowska‐Curie National Institute of Oncology Department of Clinical Oncology Kraków Poland
| | - C. Tam
- Peter MacCallum Cancer Centre & St. Vincent's Hospital Department of Haematology Melbourne Australia
| | - K. Eckert
- Pharmacyclics LLC an AbbVie Company, Oncology Division Sunnyvale California USA
| | - J. Lin
- Pharmacyclics LLC an AbbVie Company, Department of Biostatistics Sunnyval California USA
| | - J. K. Neuenburg
- Pharmacyclics LLC an AbbVie Company, Oncology Division Sunnyvale California USA
| | - M. L. Wang
- MD Anderson Cancer Center Department of Lymphoma – Myeloma Houston Texas USA
| |
Collapse
|
8
|
Chen L, Yokoyama W, Liang R, Tam C, Miller J, Zhong F. Remodeling of β-Carotene-Encapsulated Protein-Stabilized Nanoparticles during Gastrointestinal Digestion In Vitro and in Mice. J Agric Food Chem 2020; 68:15468-15477. [PMID: 33337896 DOI: 10.1021/acs.jafc.0c05322] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
The remodeling of β-carotene-encapsulated protein nanoparticles (NPs) during digestion in vitro and in vivo was investigated. The NPs were formed using three different proteins. Hydrolysis of the surface protein during digestion resulted in structure remodeling of NPs and the formation of small-sized micellar-like aggregates below 100 nm, accelerating the release of β-carotene into the aqueous phase. However, the reduced surface ζ-potential in the intestinal fluid suggested the adsorption of bile salts, favoring the formation of small-sized micellar-like aggregates. A shifted peak of β-carotene in the micellar phase from 965 cm-1 to about 855 cm-1 in Fourier transform infrared spectroscopy analysis indicated that β-carotene existed in the amorphous state. Microstructure observation in vivo further confirmed that β-carotene was loaded in micellar-like aggregates and dispersed uniformly in water. The cellular uptake study showed that the absorption rate of digested NPs was significantly increased by 1.34- to 4.16-fold when compared with undigested NPs.
Collapse
Affiliation(s)
- Ling Chen
- Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, Jiangnan University, Wuxi 214122, China
- School of Food Science and Technology, Jiangnan University, Wuxi 214122, China
| | - Wallace Yokoyama
- Western Regional Research Center, ARS, USDA, Albany, California 94710, United States
| | - Rong Liang
- Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, School of Chemical and Material Engineering, Jiangnan University, Wuxi 214122, China
| | - Christina Tam
- Western Regional Research Center, ARS, USDA, Albany, California 94710, United States
| | - Jackie Miller
- Western Regional Research Center, ARS, USDA, Albany, California 94710, United States
| | - Fang Zhong
- Key Laboratory of Synthetic and Biological Colloids, Ministry of Education, Jiangnan University, Wuxi 214122, China
- School of Food Science and Technology, Jiangnan University, Wuxi 214122, China
| |
Collapse
|
9
|
Vishakha V, Offeddu V, Soe P, Tam C. Understanding parental decision-making for childhood influenza vaccination in Singapore: A qualitative study. Int J Infect Dis 2020. [DOI: 10.1016/j.ijid.2020.09.1237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
10
|
Huynh C, Hemavathi M, Aiello M, Clancy M, Kennedy B, Knox J, Phillips E, Terry D, Khan A, Rutherford G, Symons H, Chauhan V, England HE, Tam C. 129 Interim evaluation of a clinical educators pilot study via a multi-stakeholder online survey. Arch Emerg Med 2020. [DOI: 10.1136/emj-2020-rcemabstracts.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
Aims/Objectives/BackgroundIn England, the demand for emergency care is increasing, confounded by challenges with recruitment and retention of multi-professional teams in Emergency Departments (ED). The intense working environment that clinical ED staff face is recognised as a cause of staff dissatisfaction, attrition and premature career ‘burnout.’ A new ‘shop floor’ Clinical Educator (CE) role may improve the retention and wellbeing of multi-professional ED teams. A Health Education England pilot developed and recruited CEs across 54 acute trust EDs in England, from 2017. Aston University and the Royal College of Emergency Medicine were jointly commissioned to undertake a service benefit evaluation.Methods/DesignAn online survey was circulated to CEs, learners and managers across the 54 study sites. Each group answered questions relating to experiences, opinions and reflections. Topics included impact of a CE on patient flow, confidence and competence of staff, as well as sustainability and any impact on staff wellbeing.Results/ConclusionsResults314 individuals accessed the survey and 291 eligible respondents completed it, including: 187 learners, 65 CEs and 39 ED Clinical Directors/Managers.Learners (169/187), CE (63/65) and managers (39/39) saw no change/an improvement in patient flow.100% of CEs felt that a CE in the ED improved competence and confidence of staff (88.2% of learners, 89.7% of managers).7% (61/65) of CEs and 87.2% (34/39) managers agree that CEs have improved wellbeing of staff.8% of managers (26/39) were unsure whether the CE role would be funded beyond the pilot, but 66.7% (26/39) strongly supported continuation of the CE role.ConclusionInterim evidence suggests that CEs positively impact the multi-professional ED workforce.
Collapse
|
11
|
Lim J, Ty C, Huy S, Tam C. Perceptions of antibiotic use in rural Cambodian farming communities. Int J Infect Dis 2020. [DOI: 10.1016/j.ijid.2020.09.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
12
|
Rozental O, Thalappillil R, Tam C. Mechanical valve prosthesis in pregnant patients. J Cardiothorac Vasc Anesth 2020. [DOI: 10.1053/j.jvca.2020.09.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
13
|
Thalappillil R, Rozental O, Tam C. Managing acute biventricular dysfunction during the resource-limited COVID-19 Pandemic in a major city. J Cardiothorac Vasc Anesth 2020. [PMCID: PMC7598431 DOI: 10.1053/j.jvca.2020.09.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Introduction The novel coronavirus 2019 (COVID-19) and ensuing pandemic placed significant pressure on the care of critically ill patients. We present a case of a patient presenting with acute onset left ventricular systolic failure with acute right ventricular dysfunction and unremitting supraventricular tachycardia. Methods A 69 year-old male presented with severe shortness of breath and fever to the emergency department in March of 2020 to a major city hospital in the midst of the resource-limited height of the COVID-19 pandemic. After a thorough history, physical exam, laboratory evaluation, and preliminary point-of-care ultrasonographic examination he was found to be have COVID-19 and mild acute respiratory distress syndrome (ARDS). He was managed initially with non-invasive ventilation, but on hospital day #6, was found to be profoundly hypoxic, confused, and tachycardic. On further evaluation, his vital signs demonstrated a fever of 38.2 C, tachycardia at 140 bpm, blood pressure 125/70 and SpO2 92% on 100% FiO2. Bedside transthoracic echocardiography demonstrated globally severely reduced left ventricular systolic function and a dilated right ventricle with severely reduced systolic function. An electrocardiogram demonstrated monomorphic supraventricular tachycardia. Results We describe the patient's prolonged hospital course extending forty-five days with nearly half requiring critical care. The patient eventually improved and was discharged from the hospital. Discussion We discuss the implications of resource-limited pandemic conditions in the care of critically ill patients. We incorporate the international experience of developed countries in facing a once-in-a-lifetime global medical emergency. In addition, we comment on the proposed ethical considerations when allocating patients to a significantly high level-of-care and the implications of this decision for other patients requiring care.
Collapse
|
14
|
Bachanova V, Westin J, Tam C, Borchmann P, Jaeger U, McGuirk J, Holte H, Waller E, Jaglowski S, Bishop M, Andreadis C, Foley S, Fleury I, Teshima T, Mielke S, Salles G, Ho P, Izutsu K, Maziarz R, Van Besien K, Kersten M, Wagner-Johnston N, Kato K, Corradini P, Han X, Agoulnik S, Chu J, Eldjerou L, Pacaud L, Schuster S. CORRELATIVE ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROLOGICAL EVENTS IN TISAGENLECLEUCEL-TREATED RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS. Hematol Oncol 2019. [DOI: 10.1002/hon.118_2630] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- V. Bachanova
- Division of Hematology; Oncology and Transplantation, University of Minnesota; Minneapolis United States
| | - J. Westin
- Department of Lymphoma & Meyloma; M.D. Anderson Cancer Center; Houston United States
| | - C. Tam
- Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - P. Borchmann
- Department of Hematology/Oncology; University Hospital of Cologne; Cologne Germany
| | - U. Jaeger
- Department of Hematology/Hemostaseology; Medical University Vienna; Vienna Austria
| | - J. McGuirk
- Division of Hematologic Malignancies and Cellular Therapeutics; Kansas Hospital and Medical Center; Kansas City United States
| | - H. Holte
- Lymphoma Section; University of Oslo; Oslo Norway
| | - E. Waller
- Department of Stem Cell Transplantation and Immunology; Emory University School of Medicine; Atlanta United States
| | - S. Jaglowski
- Department of Internal Medicine; The Ohio State University; Columbus United States
| | - M. Bishop
- Section of Hematology/Oncology; University of Chicago; Chicago United States
| | - C. Andreadis
- Department of Hematology and Blood and Marrow Transplat; University of California San Francisco; San Francisco United States
| | - S.R. Foley
- Division of Clinical Pathology; McMaster University; Hamilton Canada
| | - I. Fleury
- Department of Hematology; Hôpital Maisonneuve-Rosemont; Montreal Canada
| | - T. Teshima
- Department of Hematology; Hokkaido University Hospital; Sapporo Japan
| | - S. Mielke
- Department of Internal Medicine; University Hospital Wuerzburg; Wuerzburg Germany
| | - G. Salles
- Hematology Department; Lyon-Sud Hospital Center; Pierre-Benite France
| | - P.J. Ho
- Department of Haematology; Royal Prince Alfred Hospital; Camperdown Australia
| | - K. Izutsu
- Department of Hematology; National Cancer Center Hospital; Tokyo Japan
| | - R. Maziarz
- Department of Hematology and Oncology; Oregon Health and Science University; Portland United States
| | - K. Van Besien
- Department of Medical Oncology; Weill Cornell Medicine; New York United States
| | - M.J. Kersten
- Department of Hematology; Academic Medical Center; Amsterdam Netherlands
| | - N. Wagner-Johnston
- Department of Oncology and Hematologic Malignancies; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center; Baltimore United States
| | - K. Kato
- Hematology; Oncology & Cardiovascular Medicine, Kyushu University; Fukuoka Prefecture Japan
| | - P. Corradini
- Department of Oncology and Hemato-oncology; University of Milan; Milan Italy
| | - X. Han
- Biomarkers and Diagnostics Biometrics; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - S. Agoulnik
- Precision Medicine; Novartis Pharmaceuticals Corporation; Cambridge United States
| | - J. Chu
- Novartis Oncology; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - L. Eldjerou
- Global Cell & Gene Medical Affairs; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - L. Pacaud
- Novartis Oncology; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - S. Schuster
- Division of Hematology Oncology; University of Pennsylvania; Philadelphia United States
| |
Collapse
|
15
|
Wang M, Ramchandren R, Chen R, Karlin L, Chong G, Jurczak W, Wu K, Bishton M, Collins G, Eliadis P, Peyrade F, Freise K, Sukbuntherng J, Lee Y, Dobkowska E, Fedorov V, Neuenburg J, Tam C. RESULTS FROM THE SAFETY RUN-IN PERIOD OF THE SYMPATICO STUDY EVALUATING IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.146_2630] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- M. Wang
- Department of Lymphoma/Myeloma; University of Texas MD Anderson Cancer Center; Houston United States
| | - R. Ramchandren
- Department of Oncology; Karmanos Cancer Institute; Detroit United States
| | - R. Chen
- Department of Hematology & Hematopoietic Cell Transplantation; City of Hope; Duarte United States
| | - L. Karlin
- Department of Hematology; Centre Hospitalier Lyon Sud; Pierre-Bénite France
| | - G. Chong
- Department of Medical Oncology and Clinical Haematology; Olivia Newton-John Cancer Centre, and University of Melbourne; Melbourne Australia
| | - W. Jurczak
- Department of Hematology; Jagiellonian University; Kraków Poland
| | - K. Wu
- Department of Hematology; Ziekenhuis Netwerk Antwerpen; Antwerp Belgium
| | - M. Bishton
- Department of Clinical Haematology; Nottingham University Hospitals NHS Trust; Nottingham United Kingdom
| | - G. Collins
- Department of Hematology; Oxford University Hospitals, NHS Foundation Trust; Oxford United Kingdom
| | - P. Eliadis
- Department of Oncology; ICON Cancer Care; South Brisbane Australia
| | - F. Peyrade
- Department of Oncology; Centre Antoine Lacassagne; Nice France
| | - K. Freise
- Department of Clinical Pharmacology and Pharmacometrics; AbbVie Inc; North Chicago United States
| | - J. Sukbuntherng
- Department of Drug Metabolism & Pharmacokinetics; Pharmacyclics LLC, an AbbVie Company; Sunnyvale United States
| | - Y. Lee
- Department of Biostatistics; Pharmacyclics LLC, an AbbVie Company; Sunnyvale United States
| | - E. Dobkowska
- Department of Clinical Science; Pharmacyclics LLC, an AbbVie Company; Sunnyvale United States
| | - V. Fedorov
- Department of Clinical Science; Pharmacyclics LLC, an AbbVie Company; Sunnyvale United States
| | - J. Neuenburg
- Department of Clinical Science; Pharmacyclics LLC, an AbbVie Company; Sunnyvale United States
| | - C. Tam
- Department of Haematology; Peter MacCallum Cancer Centre & St. Vincent's Hospital and the University of Melbourne; Melbourne Australia
| |
Collapse
|
16
|
Castillo J, Itchaki G, Paludo J, Varettoni M, Buske C, Eyre T, Chavez J, Shain K, Issa S, Palomba L, Pasvolsky O, Simpson D, Talaulikar D, Tam C, Tedeschi A, Ansell S, Nayak L, Treon S. IBRUTINIB FOR THE TREATMENT OF BING-NEEL SYNDROME: A RETROSPECTIVE, MULTICENTER STUDY. Hematol Oncol 2019. [DOI: 10.1002/hon.140_2629] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- J. Castillo
- Bing Center for Waldenstrom Macroglobulinemia; Dana-Farber Cancer Institute; Boston United States
| | - G. Itchaki
- Hematology; Rabin Medical Center; Petah Tikva Israel
| | - J. Paludo
- Hematology and Oncology; Mayo Clinic; Rochester United States
| | - M. Varettoni
- Hematology; Fondazione IRCCS Policlinico San Matteo; Pavia Italy
| | - C. Buske
- Comprehensive Cancer Center; University Hospital Ulm; Ulm Germany
| | - T. Eyre
- Hematology; Churchill Hospital; Oxford United Kingdom
| | - J. Chavez
- Malignant Hematology; Moffitt Cancer Institute; Tampa United States
| | - K. Shain
- Malignant Hematology; Moffitt Cancer Institute; Tampa United States
| | - S. Issa
- Hematology; Middlemore Hospital; Auckland New Zealand
| | - L. Palomba
- Hematology and Oncology; Memorial Sloan Kettering Cancer Center; New York United States
| | - O. Pasvolsky
- Hematology; Rabin Medical Center; Petah Tikva Israel
| | - D. Simpson
- Hematology; North Shore Hospital; Auckland New Zealand
| | | | - C. Tam
- Hematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | | | - S. Ansell
- Hematology and Oncology; Mayo Clinic; Rochester United States
| | - L. Nayak
- Center for CNS Lymphoma; Dana-Farber Cancer Institute; Boston United States
| | - S. Treon
- Bing Center for Waldenstrom Macroglobulinemia; Dana-Farber Cancer Institute; Boston United States
| |
Collapse
|
17
|
Jaeger U, Tam C, Borchmann P, McGuirk J, Holte H, Waller E, Jaglowski S, Andreadis C, Foley S, Fleury I, Westin J, Teshima T, Mielke S, Salles G, Ho P, Izutsu K, Schuster S, Bachanova V, Maziarz R, Van Besien K, Kersten M, Wagner-Johnston N, Kato K, Corradini P, Tiwari R, Forcina A, Pacaud L, Bishop M. INTRAVENOUS IMMUNOGLOBULIN THERAPY USE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL IN THE JULIET TRIAL. Hematol Oncol 2019. [DOI: 10.1002/hon.189_2631] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- U. Jaeger
- Hematology and Hemostaseology; and Comprehensive Cancer Center, Medical University of Vienna; Vienna Austria
| | - C. Tam
- Department of Hematology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - P. Borchmann
- Department of Hematology/Oncology; University Hospital of Cologne; Cologne Germany
| | - J. McGuirk
- Division of Hematologic Malignancies and Cellular Therapeutics; Kansas Hospital and Medical Center; Kansas City United States
| | - H. Holte
- Lymphoma Section; University of Oslo, Oslo
| | - E. Waller
- Hematology and Medical Oncology; Medicine and Pathology, Emory University School of Medicine; Atlanta United States
| | - S. Jaglowski
- Department of Hematology; Ohio State University, Columbus
| | - C. Andreadis
- Department of Hematology and Blood and Marrow Transplant; University of California San Francisco; San Francisco United States
| | - S.R. Foley
- Division of Clinical Pathology; McMaster University; Hamilton Canada
| | - I. Fleury
- Department of Hematology; Hôpital Maisonneuve-Rosemont; Montreal Canada
| | - J. Westin
- Department of Lymphoma & Meyloma; MD Anderson Cancer Center; Houston United States
| | - T. Teshima
- Department of Hematology; Hokkaido University Hospital; Sapporo Japan
| | - S. Mielke
- Department of Internal Medicine; University Hospital Wuerzburg; Wuerzburg Germany
| | - G. Salles
- Department of Hematology/Oncology; Hospital Center Lyon-Sud; Pierre-Benite France
| | - P.J. Ho
- Department of Haematology; Royal Prince Alfred Hospital; Camperdown Australia
| | - K. Izutsu
- Department of Hematology; National Cancer Center Hospital; Tokyo Japan
| | - S. Schuster
- Division of Hematology Oncology; University of Pennsylvania; Philadelphia United States
| | - V. Bachanova
- Division of Hematology; Oncology and Transplantation, University of Minnesota; Minneapolis United States
| | - R. Maziarz
- Department of Hematology; Oregon Health and Science University; Portland United States
| | - K. Van Besien
- Department of Medical Oncology; Weill Cornell Medicine; New York United States
| | - M.J. Kersten
- Department of Hematology; Academic Medical Center; Amsterdam Netherlands
| | - N. Wagner-Johnston
- Department of Hematology/Oncology; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center; Baltimore United States
| | - K. Kato
- Department of Haematology; Kyushu University Hospital; Fukuoka Prefecture Japan
| | - P. Corradini
- Department of Oncology and Hemato-oncology; University of Milan; Milan Italy
| | - R. Tiwari
- Global Medical Affaris; Novartis Pharmaceuticals Corporation; Hyderabad India
| | - A. Forcina
- Novartis Oncology; Novartis Pharma AG; Basel Switzerland
| | - L. Pacaud
- Novartis Oncology; Novartis Pharmaceuticals Corporation; East Hanover United States
| | - M. Bishop
- Section of Hematology/Oncology; University of Chicago; Chicago United States
| |
Collapse
|
18
|
Kumar S, Bains T, Won Kim AS, Tam C, Kim J, Cheng LW, Land KM, Debnath A, Kumar V. Highly Potent 1 H-1,2,3-Triazole-Tethered Isatin-Metronidazole Conjugates Against Anaerobic Foodborne, Waterborne, and Sexually-Transmitted Protozoal Parasites. Front Cell Infect Microbiol 2018; 8:380. [PMID: 30425970 PMCID: PMC6218680 DOI: 10.3389/fcimb.2018.00380] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2018] [Accepted: 10/09/2018] [Indexed: 12/26/2022] Open
Abstract
Parasitic infections like amebiasis, trichomoniasis, and giardiasis are major health threats in tropical and subtropical regions of the world. Metronidazole (MTZ) is the current drug of choice for amebiasis, giardiasis, and trichomoniasis but it has several adverse effects and potential resistance is a concern. In order to develop alternative antimicrobials, a library of 1H-1,2,3-triazole-tethered metronidazole-isatin conjugates was synthesized using Huisgen's azide-alkyne cycloaddition reaction and evaluated for their amebicidal, anti-trichomonal, and anti-giardial potential. Most of the synthesized conjugates exhibited activities against Trichomonas vaginalis, Tritrichomonas foetus, Entamoeba histolytica, and Giardia lamblia. While activities against T. vaginalis and T. foetus were comparable to that of the standard drug MTZ, better activities were observed against E. histolytica and G. lamblia. Conjugates 9d and 10a were found to be 2–3-folds more potent than MTZ against E. histolytica and 8–16-folds more potent than MTZ against G. lamblia. Further analysis of these compounds on fungi and bacteria did not show inhibitory activity, demonstrating their specific anti-protozoal properties.
Collapse
Affiliation(s)
- Sumit Kumar
- Department of Chemistry, Guru Nanak Dev University, Amritsar, India
| | - Trpta Bains
- Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, United States
| | - Ashley Sae Won Kim
- Department of Biological Sciences, University of the Pacific, Stockton, CA, United States
| | - Christina Tam
- Foodborne Toxin Detection and Prevention Research Unit, Agricultural Research Service, United States Department of Agriculture, Albany, CA, United States
| | - Jong Kim
- Foodborne Toxin Detection and Prevention Research Unit, Agricultural Research Service, United States Department of Agriculture, Albany, CA, United States
| | - Luisa W Cheng
- Foodborne Toxin Detection and Prevention Research Unit, Agricultural Research Service, United States Department of Agriculture, Albany, CA, United States
| | - Kirkwood M Land
- Department of Biological Sciences, University of the Pacific, Stockton, CA, United States
| | - Anjan Debnath
- Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, United States
| | - Vipan Kumar
- Department of Chemistry, Guru Nanak Dev University, Amritsar, India
| |
Collapse
|
19
|
Friedman M, Huang V, Quiambao Q, Noritake S, Liu J, Kwon O, Chintalapati S, Young J, Levin CE, Tam C, Cheng LW, Land KM. Potato Peels and Their Bioactive Glycoalkaloids and Phenolic Compounds Inhibit the Growth of Pathogenic Trichomonads. J Agric Food Chem 2018; 66:7942-7947. [PMID: 30039703 DOI: 10.1021/acs.jafc.8b01726] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Potato peel, a waste product of the potato processing industry, is high in bioactive compounds. We investigated the in vitro antitrichomonad activity of potato peel powders prepared from commercial Russet, red, purple, and fingerling varieties as well as several known potato components, alkaloids and phenolic compounds, against three pathogenic strains of trichomonads. Trichomonas vaginalis is a sexually transmitted protozoan parasite that causes the human disease trichomoniasis. Two distinct strains of the related Tritrichomonas fetus infect cattle and cats. The glycoalkaloids α-chaconine and α-solanine were highly active against all parasite lines, while their common aglycone solanidine was only mildly inhibitory. α-Solanine was several times more active than α-chaconine. The phenolic compounds caffeic and chlorogenic acids and quercetin were mildly active against the parasites. Most of the potato peel samples were at least somewhat active against all three trichomonad species, but their activities were wide-ranging and did not correspond to their glycoalkaloid and phenolic content determined by HPLC. The two Russet samples were the most active against all three parasites. The purple potato peel sample was highly active against bovine and mostly inactive against feline trichomonads. None of the test substances were inhibitory toward several normal microflora species, suggesting the potential use of the peels for targeted therapeutic treatments against trichomonads.
Collapse
Affiliation(s)
- Mendel Friedman
- Healthy Processed Foods Research Unit, Agricultural Research Service , United States Department of Agriculture , Albany , California 94556 , United States
| | - Vincent Huang
- Department of Biological Sciences , University of the Pacific , Stockton , California 95211 , United States
| | - Quincel Quiambao
- Department of Biological Sciences , University of the Pacific , Stockton , California 95211 , United States
| | - Sabrina Noritake
- Department of Biological Sciences , University of the Pacific , Stockton , California 95211 , United States
| | - Jenny Liu
- Department of Biological Sciences , University of the Pacific , Stockton , California 95211 , United States
| | - Ohkun Kwon
- Department of Biological Sciences , University of the Pacific , Stockton , California 95211 , United States
| | - Sirisha Chintalapati
- Department of Biological Sciences , University of the Pacific , Stockton , California 95211 , United States
| | - Joseph Young
- Department of Biological Sciences , University of the Pacific , Stockton , California 95211 , United States
| | - Carol E Levin
- Healthy Processed Foods Research Unit, Agricultural Research Service , United States Department of Agriculture , Albany , California 94556 , United States
| | - Christina Tam
- Foodborne Toxins Detection and Prevention Research Unit, Agricultural Research Service , United States Department of Agriculture , Albany , California 94556 , United States
| | - Luisa W Cheng
- Foodborne Toxins Detection and Prevention Research Unit, Agricultural Research Service , United States Department of Agriculture , Albany , California 94556 , United States
| | - Kirkwood M Land
- Department of Biological Sciences , University of the Pacific , Stockton , California 95211 , United States
| |
Collapse
|
20
|
Chellan P, Avery VM, Duffy S, Triccas JA, Nagalingam G, Tam C, Cheng LW, Liu J, Land KM, Clarkson GJ, Romero-Canelón I, Sadler PJ. Organometallic Conjugates of the Drug Sulfadoxine for Combatting Antimicrobial Resistance. Chemistry 2018; 24:10078-10090. [PMID: 29653033 DOI: 10.1002/chem.201801090] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2018] [Revised: 04/03/2018] [Indexed: 01/24/2023]
Abstract
Fourteen novel arene RuII , and cyclopentadienyl (Cpx ) RhIII and IrIII complexes containing an N,N'-chelated pyridylimino- or quinolylimino ligand functionalized with the antimalarial drug sulfadoxine have been synthesized and characterized, including three by X-ray crystallography. The rhodium and iridium complexes exhibited potent antiplasmodial activity with IC50 values of 0.10-2.0 μm in either all, or one of the three Plasmodium falciparum assays (3D7 chloroquine sensitive, Dd2 chloroquine resistant and NF54 sexual late stage gametocytes) but were only moderately active towards Trichomonas vaginalis. They were active in both the asexual blood stage and the sexual late stage gametocyte assays, whereas the clinical parent drug, sulfadoxine, was inactive. Five complexes were moderately active against Mycobacterium tuberculosis (IC50 <6.3 μm), while sulfadoxine showed no antitubercular activity. An increase in the size of both the Cpx ligand and the aromatic imino substituent increased hydrophobicity, which resulted in an increase in antiplasmodial activity.
Collapse
Affiliation(s)
- Prinessa Chellan
- Department of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.,Current address: Stellenbosch University, Matieland, Western Cape, South Africa
| | - Vicky M Avery
- Discovery Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland, 4111, Australia
| | - Sandra Duffy
- Discovery Biology, Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland, 4111, Australia
| | - James A Triccas
- Microbial Immunity and Pathogenesis Group, Department of, Infectious Diseases and Immunology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia
| | - Gayathri Nagalingam
- Microbial Immunity and Pathogenesis Group, Department of, Infectious Diseases and Immunology, Sydney Medical School, The University of Sydney, Sydney, NSW, 2006, Australia
| | - Christina Tam
- Foodborne Toxin Detection and Prevention Research Unit, Agricultural Research Service, United States Department of Agriculture, Albany, CA, 94710, USA
| | - Luisa W Cheng
- Foodborne Toxin Detection and Prevention Research Unit, Agricultural Research Service, United States Department of Agriculture, Albany, CA, 94710, USA
| | - Jenny Liu
- Department of Biological Sciences, University of the Pacific, Stockton, CA, 95211, USA
| | - Kirkwood M Land
- Department of Biological Sciences, University of the Pacific, Stockton, CA, 95211, USA
| | - Guy J Clarkson
- Department of Chemistry, University of Warwick, Coventry, CV4 7AL, UK
| | - Isolda Romero-Canelón
- Department of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.,School of Pharmacy, University of Birmingham, Birmingham, B15 2TT, UK
| | - Peter J Sadler
- Department of Chemistry, University of Warwick, Coventry, CV4 7AL, UK
| |
Collapse
|
21
|
Chellan P, Avery VM, Duffy S, Triccas JA, Nagalingam G, Tam C, Cheng LW, Liu J, Land KM, Clarkson GJ, Romero‐Canelón I, Sadler PJ. Frontispiece: Organometallic Conjugates of the Drug Sulfadoxine for Combatting Antimicrobial Resistance. Chemistry 2018. [DOI: 10.1002/chem.201884064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Prinessa Chellan
- Department of Chemistry University of Warwick Coventry CV4 7AL UK
- Current address: Stellenbosch University Matieland Western Cape South Africa
| | - Vicky M. Avery
- Discovery Biology, Griffith Institute for Drug Discovery Griffith University Nathan Queensland 4111 Australia
| | - Sandra Duffy
- Discovery Biology, Griffith Institute for Drug Discovery Griffith University Nathan Queensland 4111 Australia
| | - James A. Triccas
- Microbial Immunity and Pathogenesis Group, Department of, Infectious Diseases and Immunology, Sydney Medical School The University of Sydney Sydney NSW 2006 Australia
| | - Gayathri Nagalingam
- Microbial Immunity and Pathogenesis Group, Department of, Infectious Diseases and Immunology, Sydney Medical School The University of Sydney Sydney NSW 2006 Australia
| | - Christina Tam
- Foodborne Toxin Detection and Prevention Research Unit, Agricultural Research Service United States Department of Agriculture Albany CA 94710 USA
| | - Luisa W. Cheng
- Foodborne Toxin Detection and Prevention Research Unit, Agricultural Research Service United States Department of Agriculture Albany CA 94710 USA
| | - Jenny Liu
- Department of Biological Sciences University of the Pacific Stockton CA 95211 USA
| | - Kirkwood M. Land
- Department of Biological Sciences University of the Pacific Stockton CA 95211 USA
| | - Guy J. Clarkson
- Department of Chemistry University of Warwick Coventry CV4 7AL UK
| | - Isolda Romero‐Canelón
- Department of Chemistry University of Warwick Coventry CV4 7AL UK
- School of Pharmacy University of Birmingham Birmingham B15 2TT UK
| | - Peter J. Sadler
- Department of Chemistry University of Warwick Coventry CV4 7AL UK
| |
Collapse
|
22
|
Singh A, Fong G, Liu J, Wu YH, Chang K, Park W, Kim J, Tam C, Cheng LW, Land KM, Kumar V. Synthesis and Preliminary Antimicrobial Analysis of Isatin-Ferrocene and Isatin-Ferrocenyl Chalcone Conjugates. ACS Omega 2018; 3:5808-5813. [PMID: 30023926 PMCID: PMC6045481 DOI: 10.1021/acsomega.8b00553] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/23/2018] [Accepted: 05/17/2018] [Indexed: 05/30/2023]
Abstract
In this study, we outline the synthesis of isatin-ferrocenyl chalcone and 1H-1,2,3-triazole-tethered isatin-ferrocene conjugates along with their antimicrobial evaluation against the human mucosal pathogen Trichomonas vaginalis. The introduction of a triazole ring among the synthesized conjugates improved the activity profiles with most of the compounds in the library, exhibiting 100% growth inhibition in a preliminary susceptibility screen at 100 μM. IC50 determination of the most potent compounds in the set revealed an inhibitory range between 2 and 13 μM. Normal flora microbiome are unaffected by these compounds, suggesting that these may be new chemical scaffolds for the discovery of new drugs against trichomonad infections.
Collapse
Affiliation(s)
- Amandeep Singh
- Department
of Chemistry, Guru Nanak Dev University, Amritsar 143005, Punjab, India
| | - Grant Fong
- Department
of Biological Sciences, University of the
Pacific, Stockton, California 95211, United States
| | - Jenny Liu
- Department
of Biological Sciences, University of the
Pacific, Stockton, California 95211, United States
| | - Yun-Hsuan Wu
- Department
of Biological Sciences, University of the
Pacific, Stockton, California 95211, United States
| | - Kevin Chang
- Department
of Biological Sciences, University of the
Pacific, Stockton, California 95211, United States
| | - William Park
- Department
of Biological Sciences, University of the
Pacific, Stockton, California 95211, United States
| | - Jihwan Kim
- Department
of Biological Sciences, University of the
Pacific, Stockton, California 95211, United States
| | - Christina Tam
- Foodborne
Toxin Detection and Prevention Research Unit, Agricultural Research
Service, United States Department of Agriculture, Albany, California 94710, United States
| | - Luisa W. Cheng
- Foodborne
Toxin Detection and Prevention Research Unit, Agricultural Research
Service, United States Department of Agriculture, Albany, California 94710, United States
| | - Kirkwood M. Land
- Department
of Biological Sciences, University of the
Pacific, Stockton, California 95211, United States
| | - Vipan Kumar
- Department
of Chemistry, Guru Nanak Dev University, Amritsar 143005, Punjab, India
| |
Collapse
|
23
|
Singh A, Nisha, Bains T, Hahn HJ, Liu N, Tam C, Cheng LW, Kim J, Debnath A, Land KM, Kumar V. Design, Synthesis and Preliminary Antimicrobial Evaluation of N-Alkyl Chain Tethered C-5 Functionalized Bis-Isatins. Medchemcomm 2017; 8:1982-1992. [PMID: 29449910 DOI: 10.1039/c7md00434f] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
A series of N-alkyl tethered C-5 functionalized bis-isatins were synthesized and evaluated for antimicrobial activity against pathogenic microorganisms. The preliminary evaluation studies revealed the compound 4t, with an optimal combination of bromo-substituent at the C-5 position of isatin ring along with propyl chain linker being most active among the synthesized series exhibiting an IC50 value of 3.72 μM against Trichomonas vaginalis while 4j exhibited an IC50 value of 14.8 μM against Naegleria fowleri, more effective than the standard drug Miltefosine. The compound 3f with an octyl spacer length was the most potent among the series against Giardia lamblia with an IC50 of 18.4 μM while 3d exhibited an IC50 of 23 μM against Entamoeba histolytica. This library was also screened against the fungal pathogen Aspergillus parasiticus. A number of the compounds demonstrated potency against this fungus, illustrating a possible broad-spectrum activity. Furthermore, an evaluation of these synthesized compounds against a panel of normal flora bacteria revealed them to be non-cytotoxic, demonstrating the selectivity of these compounds. This observation, in combination with previous studies that isatin is non-toxic to humans, presents a new possible scaffold for drug discovery against these important protozoal pathogens of humans and animals.
Collapse
Affiliation(s)
- Amandeep Singh
- Department of Chemistry, Guru Nanak Dev University, Amritsar 143005, India
| | - Nisha
- Department of Chemistry, Guru Nanak Dev University, Amritsar 143005, India
| | - Trpta Bains
- Centre for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA
| | - Hye Jee Hahn
- Centre for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA
| | - Nicole Liu
- Department of Biological Sciences, University of the Pacific, Stockton, CA 95211, USA
| | - Christina Tam
- Foodborne Toxin Detection and Prevention Research Unit, Agricultural Research Service, United States Department of Agriculture, Albany, CA 94710, USA
| | - Luisa W Cheng
- Foodborne Toxin Detection and Prevention Research Unit, Agricultural Research Service, United States Department of Agriculture, Albany, CA 94710, USA
| | - Jong Kim
- Foodborne Toxin Detection and Prevention Research Unit, Agricultural Research Service, United States Department of Agriculture, Albany, CA 94710, USA
| | - Anjan Debnath
- Centre for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA
| | - Kirkwood M Land
- Department of Biological Sciences, University of the Pacific, Stockton, CA 95211, USA
| | - Vipan Kumar
- Department of Chemistry, Guru Nanak Dev University, Amritsar 143005, India
| |
Collapse
|
24
|
Noritake SM, Liu J, Kanetake S, Levin CE, Tam C, Cheng LW, Land KM, Friedman M. Phytochemical-rich foods inhibit the growth of pathogenic trichomonads. Altern Ther Health Med 2017; 17:461. [PMID: 28903731 PMCID: PMC5598040 DOI: 10.1186/s12906-017-1967-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2017] [Accepted: 09/05/2017] [Indexed: 12/29/2022]
Abstract
Background Plants produce secondary metabolites that often possess widespread bioactivity, and are then known as phytochemicals. We previously determined that several phytochemical-rich food-derived preparations were active against pathogenic foodborne bacteria. Trichomonads produce disease (trichomoniasis) in humans and in certain animals. Trichomonads are increasingly becoming resistant to conventional modes of treatment. It is of interest to test bioactive, natural compounds for efficacy against these pathogens. Methods Using a cell assay, black tea, green tea, grape, pomegranate, and jujube extracts, as well as whole dried jujube were tested against three trichomonads: Trichomonas vaginalis strain G3 (found in humans), Tritrichomonas foetus strain D1 (found in cattle), and Tritrichomonas foetus-like organism strain C1 (found in cats). The most effective of the test substances was subsequently tested against two metronidazole-resistant Trichomonas vaginalis strains, and on normal mucosal flora. Results Black tea extract inhibited all the tested trichomonads, but was most effective against the T. vaginalis organisms. Inhibition by black tea was correlated with the total and individual theaflavin content of the two tea extracts determined by HPLC. Metronidazole-resistant Trichomonas vaginalis strains were also inhibited by the black tea extract. The response of the organisms to the remaining preparations was variable and unique. We observed no effect of the black tea extract on common normal flora bacteria. Conclusions The results suggest that the black tea, and to a lesser degree green tea, grape seed, and pomegranate extracts might present possible natural alternative therapeutic agents to treat Trichomonas vaginalis infections in humans and the related trichomonad infections in animals, without negatively affecting the normal flora.
Collapse
|
25
|
Schuster S, Bishop M, Tam C, Waller E, Borchmann P, Mcguirk J, Jäger U, Jaglowski S, Andreadis C, Westin J, Fleury I, Bachanova V, Foley S, Ho P, Mielke S, Holte H, Anak O, Pacaud L, Awasthi R, Tai F, Salles G, Maziarz R. GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)-AN INTERIM ANALYSIS. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_6] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- S.J. Schuster
- Lymphoma Program, Abramson Cancer Center; University of Pennsylvania; Philadelphia USA
| | - M.R. Bishop
- Hematopoietic Cellular Therapy Program; The University of Chicago Medicine; Chicago USA
| | - C. Tam
- Division of Hematology and Oncology; Peter MacCallum Cancer Centre; Melbourne Australia
| | - E.K. Waller
- Department of Hematology and Medical Oncology; Emory University School of Medicine; Atlanta USA
| | - P. Borchmann
- Department of Internal Medicine; University Hospital of Cologne; Cologne Germany
| | - J. Mcguirk
- Department of Blood and Bone Marrow Transplant; The University of Kansas Cancer Center; Kansas City USA
| | - U. Jäger
- Department of Medicine I, Division of Hematology and Hemostaseology; Medical University of Vienna; Vienna Austria
| | - S. Jaglowski
- Department of Internal Medicine; The Ohio State University Wexner Medical Center; Columbus USA
| | - C. Andreadis
- Helen Diller Family Comprehensive Cancer Center; University of California San Francisco Medical Center; San Francisco USA
| | - J. Westin
- Department of Lymphoma/Myeloma; The University of Texas MD Anderson Cancer Center; Houston USA
| | - I. Fleury
- Department of Medicine, University of Montreal; Maisonneuve-Rosemont Hospital CIUSSS East; Montreal Canada
| | - V. Bachanova
- Department of Medicine; University of Minnesota; Minneapolis USA
| | - S.R. Foley
- Department of Medicine; McMaster University; Hamilton Canada
| | - P.J. Ho
- Institute of Haematology; Royal Prince Alfred Hospital & Sydney University; Sydney Australia
| | - S. Mielke
- Medizinische Klinik und Poliklinik II; Universitatsklinikum Würzburg; Würzburg Germany
| | - H. Holte
- Department of Oncology; Oslo University Hospital; Oslo Norway
| | - O. Anak
- Global Drug Development; Novartis Pharma AG; Basel Switzerland
| | - L. Pacaud
- Global Drug Development; Novartis Pharma AG; Basel Switzerland
| | - R. Awasthi
- PK Sciences; Novartis Pharmaceuticals Corporation; East Hanover USA
| | - F. Tai
- Biostatistics; Novartis Pharmaceuticals Corporation; East Hanover USA
| | - G. Salles
- Hospices Civils de Lyon; Université de Lyon; Lyon France
| | - R. Maziarz
- Center for Hematologic Malignancies, Knight Cancer Institute; Oregon Health & Science University; Portland USA
| |
Collapse
|
26
|
Mason K, Sharpe C, Davis J, Koldej R, Tam C, Ritchie D. COMPARISON OF INNATE IMMUNITY CHANGES FOLLOWING IBRUTINIB AND VENETOCLAX TREATMENT OF RELAPSED CHRONIC LYMPHOCYTIC LEUKAEMIA. Hematol Oncol 2017. [DOI: 10.1002/hon.2439_148] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- K. Mason
- Department of Haematology and Bone Marrow Transplantation; The Royal Melbourne Hospital; Parkville Australia
| | - C. Sharpe
- Medicine, Dentistry and Health Sciences; The University of Melbourne; Parkville Australia
| | - J. Davis
- ACRF Translational research laboratory; The Royal Melbourne Hospital; Parkville Australia
| | - R. Koldej
- ACRF Translational research laboratory; The Royal Melbourne Hospital; Parkville Australia
| | - C. Tam
- Haematology; Peter MacCallum Cancer Centre; Parkville Australia
| | - D. Ritchie
- ACRF Translational research laboratory; The Royal Melbourne Hospital; Parkville Australia
| |
Collapse
|
27
|
Anderson M, Lew T, Seymour J, Roberts A, Tam C. OUTCOMES WITH BRUTON TYROSINE KINASE INHIBITION IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA AFTER PROGRESSION ON VENETOCLAX. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_99] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- M. Anderson
- Haematology Department; Victorian Comprehensive Cancer Centre; Melbourne Australia
| | - T.E. Lew
- Cancer and Haematology; Walter and Eliza Hall Institute; Parkville Australia
| | - J.F. Seymour
- Haematology Department; Victorian Comprehensive Cancer Centre; Melbourne Australia
| | - A.W. Roberts
- Haematology Department; Victorian Comprehensive Cancer Centre; Melbourne Australia
| | - C. Tam
- Haematology Department; Victorian Comprehensive Cancer Centre; Melbourne Australia
| |
Collapse
|
28
|
Cook WK, Tseng W, Tam C, John I, Lui C. Ethnic-group socioeconomic status as an indicator of community-level disadvantage: A study of overweight/obesity in Asian American adolescents. Soc Sci Med 2017; 184:15-22. [PMID: 28486206 DOI: 10.1016/j.socscimed.2017.04.027] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2016] [Revised: 04/13/2017] [Accepted: 04/18/2017] [Indexed: 10/19/2022]
Abstract
Asian American children and adolescents are an under-investigated subpopulation in obesity research. Informed by a wide socioeconomic diversity among Asian American ethnic groups, this study explored ethnic-group socioeconomic status (SES) as an indicator of community-level disadvantage that may influence overweight/obesity in Asian American adolescents. We hypothesized that ethnic-group SES was inversely associated with overweight/obesity in Asian American adolescents. Multiple logistic regression models were fitted using a sample of 1525 Asian American adolescents ages 12-17 from pooled 2007-2012 California Health Interview Survey (CHIS) data. Age, gender, nativity, individual-level SES (income and education), and two lifestyle variables (fast food consumption and physical activity) were controlled for. We found that adolescents in high- or middle-level SES ethnic groups were far less likely to be overweight/obese than those in low-SES ethnic groups. Further, these relationships were more pronounced for foreign-born adolescents but not significant for U.S.-born adolescents. Ethnic-group SES may be a meaningful indicator of community-level socioeconomic disparities that influence the health of Asian Americans and, potentially, other populations with high proportions of immigrants of diverse socioeconomic and ethnic backgrounds.
Collapse
Affiliation(s)
- Won Kim Cook
- Alcohol Research Group, Public Health Institute, United States.
| | | | - Christina Tam
- University of California, Berkeley & Alcohol Research Group, Public Health Institute, United States
| | - Iyanrick John
- Asian & Pacific Islander American Health Forum, United States
| | - Camillia Lui
- Alcohol Research Group, Public Health Institute, United States
| |
Collapse
|
29
|
Stringer T, Seldon R, Liu N, Warner DF, Tam C, Cheng LW, Land KM, Smith PJ, Chibale K, Smith GS. Antimicrobial activity of organometallic isonicotinyl and pyrazinyl ferrocenyl-derived complexes. Dalton Trans 2017; 46:9875-9885. [DOI: 10.1039/c7dt01952a] [Citation(s) in RCA: 42] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Isonicotinyl and pyrazinyl ferrocenyl-derived complexes were evaluatedin vitrofor antimycobacterial and antiparasitic activity.
Collapse
|
30
|
Low M, Tan H, Hartman M, Tam C. Knowledge, attitudes and practices of parents towards childhood influenza vaccination in Singapore. Int J Infect Dis 2016. [DOI: 10.1016/j.ijid.2016.11.265] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
31
|
Liu J, Kanetake S, Wu YH, Tam C, Cheng LW, Land KM, Friedman M. Antiprotozoal Effects of the Tomato Tetrasaccharide Glycoalkaloid Tomatine and the Aglycone Tomatidine on Mucosal Trichomonads. J Agric Food Chem 2016; 64:8806-8810. [PMID: 27934291 DOI: 10.1021/acs.jafc.6b04030] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
The present study investigated the inhibitory effects of the commercial tetrasaccharide tomato glycoalkaloid tomatine and the aglycone tomatidine on three mucosal pathogenic protozoa that are reported to infect humans, cattle, and cats, respectively: Trichomonas vaginalis strain G3, Tritrichomonas foetus strain D1, and Tritrichomonas foetus strain C1. A preliminary screen showed that tomatine at 100 μM concentration completely inhibited the growth of all three trichomonads. In contrast, the inhibition of all three pathogens by tomatidine was much lower, suggesting the involvement of the lycotetraose carbohydrate side chain in the mechanism of inhibition. Midpoints of concentration-response sigmoid plots of tomatine on the three strains correspond to IC50 values, the concentration that inhibits 50% of growth of the pathogenic protozoa. The concentration data were used to calculate the IC50 values for G3, D1, and C1 of 7.9, 1.9, and 2.2 μM, respectively. The results show an approximately 4-fold variation from the lowest to the highest value (lowest activity). Although the inhibition by tomatine was not as effective as that of the medicinal drug metronidazole, the relatively low IC50 values for both T. vaginalis and T. foetus indicated tomatine as a possible natural alternative therapeutic for trichomoniasis in humans and food-producing (cattle and pigs) and domestic (cats) animals. Because tomatine has the potential to serve as a new antiprotozoan functional (medical) food, the distribution of this glycoalkaloid in tomatoes and suggestions for further research are discussed.
Collapse
Affiliation(s)
- Jenny Liu
- Department of Biological Sciences, University of the Pacific , Stockton, California 95211, United States
| | - Sierra Kanetake
- Department of Biological Sciences, University of the Pacific , Stockton, California 95211, United States
| | - Yun-Hsuan Wu
- Department of Biological Sciences, University of the Pacific , Stockton, California 95211, United States
| | - Christina Tam
- Foodborne Toxin Detection and Prevention, Agricultural Research Service, United States Department of Agriculture , Albany, California 94556, United States
| | - Luisa W Cheng
- Foodborne Toxin Detection and Prevention, Agricultural Research Service, United States Department of Agriculture , Albany, California 94556, United States
| | - Kirkwood M Land
- Department of Biological Sciences, University of the Pacific , Stockton, California 95211, United States
| | - Mendel Friedman
- Healthy Processed Foods Research, Agricultural Research Service, United States Department of Agriculture , Albany, California 94556, United States
| |
Collapse
|
32
|
Hu M, Tam C, So W, Chan J, Tomlinson B, Ma R. Genetic variants and lipid traits in the Hong Kong Chinese patients with type 2 diabetes. Atherosclerosis 2016. [DOI: 10.1016/j.atherosclerosis.2016.07.729] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
33
|
Miller H, Castro-Gomes T, Corrotte M, Tam C, Maugel TK, Andrews NW, Song W. Lipid raft-dependent plasma membrane repair interferes with the activation of B lymphocytes. J Cell Biol 2016; 211:1193-205. [PMID: 26694840 PMCID: PMC4687878 DOI: 10.1083/jcb.201505030] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023] Open
Abstract
Repair of plasma membrane wounds in B lymphocytes that lack caveolin requires lysosome exocytosis and lipid raft–mediated endocytosis and inhibits activation of the B cell receptor by sequestering lipid rafts. Cells rapidly repair plasma membrane (PM) damage by a process requiring Ca2+-dependent lysosome exocytosis. Acid sphingomyelinase (ASM) released from lysosomes induces endocytosis of injured membrane through caveolae, membrane invaginations from lipid rafts. How B lymphocytes, lacking any known form of caveolin, repair membrane injury is unknown. Here we show that B lymphocytes repair PM wounds in a Ca2+-dependent manner. Wounding induces lysosome exocytosis and endocytosis of dextran and the raft-binding cholera toxin subunit B (CTB). Resealing is reduced by ASM inhibitors and ASM deficiency and enhanced or restored by extracellular exposure to sphingomyelinase. B cell activation via B cell receptors (BCRs), a process requiring lipid rafts, interferes with PM repair. Conversely, wounding inhibits BCR signaling and internalization by disrupting BCR–lipid raft coclustering and by inducing the endocytosis of raft-bound CTB separately from BCR into tubular invaginations. Thus, PM repair and B cell activation interfere with one another because of competition for lipid rafts, revealing how frequent membrane injury and repair can impair B lymphocyte–mediated immune responses.
Collapse
Affiliation(s)
- Heather Miller
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742
| | - Thiago Castro-Gomes
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742
| | - Matthias Corrotte
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742
| | - Christina Tam
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742
| | - Timothy K Maugel
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742
| | - Norma W Andrews
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742
| | - Wenxia Song
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742
| |
Collapse
|
34
|
Castro-Gomes T, Corrotte M, Tam C, Andrews NW. Plasma Membrane Repair Is Regulated Extracellularly by Proteases Released from Lysosomes. PLoS One 2016; 11:e0152583. [PMID: 27028538 PMCID: PMC4814109 DOI: 10.1371/journal.pone.0152583] [Citation(s) in RCA: 60] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2015] [Accepted: 03/16/2016] [Indexed: 12/28/2022] Open
Abstract
Eukaryotic cells rapidly repair wounds on their plasma membrane. Resealing is Ca2+-dependent, and involves exocytosis of lysosomes followed by massive endocytosis. Extracellular activity of the lysosomal enzyme acid sphingomyelinase was previously shown to promote endocytosis and wound removal. However, whether lysosomal proteases released during cell injury participate in resealing is unknown. Here we show that lysosomal proteases regulate plasma membrane repair. Extracellular proteolysis is detected shortly after cell wounding, and inhibition of this process blocks repair. Conversely, surface protein degradation facilitates plasma membrane resealing. The abundant lysosomal cysteine proteases cathepsin B and L, known to proteolytically remodel the extracellular matrix, are rapidly released upon cell injury and are required for efficient plasma membrane repair. In contrast, inhibition of aspartyl proteases or RNAi-mediated silencing of the lysosomal aspartyl protease cathepsin D enhances resealing, an effect associated with the accumulation of active acid sphingomyelinase on the cell surface. Thus, secreted lysosomal cysteine proteases may promote repair by facilitating membrane access of lysosomal acid sphingomyelinase, which promotes wound removal and is subsequently downregulated extracellularly by a process involving cathepsin D.
Collapse
Affiliation(s)
- Thiago Castro-Gomes
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, 20742, United States of America
| | - Matthias Corrotte
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, 20742, United States of America
| | - Christina Tam
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, 20742, United States of America
| | - Norma W. Andrews
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, 20742, United States of America
- * E-mail:
| |
Collapse
|
35
|
Adams M, Stringer T, de Kock C, Smith PJ, Land KM, Liu N, Tam C, Cheng LW, Njoroge M, Chibale K, Smith GS. Bioisosteric ferrocenyl-containing quinolines with antiplasmodial and antitrichomonal properties. Dalton Trans 2016; 45:19086-19095. [DOI: 10.1039/c6dt03175g] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Bioisosteric (C, Si) ferrocenyl-containing quinolines and ferrocenylamines were prepared and evaluated as antiplasmodial and antitrichomonal agents.
Collapse
|
36
|
Stringer T, De Kock C, Guzgay H, Okombo J, Liu J, Kanetake S, Kim J, Tam C, Cheng LW, Smith PJ, Hendricks DT, Land KM, Egan TJ, Smith GS. Mono- and multimeric ferrocene congeners of quinoline-based polyamines as potential antiparasitics. Dalton Trans 2016; 45:13415-26. [DOI: 10.1039/c6dt02685k] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A series of mono- and multimeric polyamine-containing ferrocenyl complexes bearing a quinoline motif were prepared.
Collapse
|
37
|
Ahuja S, Mukund S, Deng L, Khakh K, Chang E, Ho H, Shriver S, Young C, Lin S, Johnson JP, Wu P, Li J, Coons M, Tam C, Brillantes B, Sampang H, Mortara K, Bowman KK, Clark KR, Estevez A, Xie Z, Verschoof H, Grimwood M, Dehnhardt C, Andrez JC, Focken T, Sutherlin DP, Safina BS, Starovasnik MA, Ortwine DF, Franke Y, Cohen CJ, Hackos DH, Koth CM, Payandeh J. Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist. Science 2015; 350:aac5464. [DOI: 10.1126/science.aac5464] [Citation(s) in RCA: 218] [Impact Index Per Article: 24.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
|
38
|
Ho PJ, Marlton P, Tam C, Stevenson W, Ritchie D, Bird R, Dunlop LC, Durrant S, Ross DM. Practical management of myelofibrosis with ruxolitinib. Intern Med J 2015; 45:1221-30. [DOI: 10.1111/imj.12921] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2015] [Accepted: 09/17/2015] [Indexed: 12/24/2022]
Affiliation(s)
- P. J. Ho
- Institute of Haematology; Royal Prince Alfred Hospital; Sydney New South Wales Australia
- University of Sydney; Sydney New South Wales Australia
| | - P. Marlton
- Princess Alexandra Hospital; Brisbane Queensland Australia
- University of Queensland School of Medicine; Brisbane Queensland Australia
| | - C. Tam
- Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Victoria Australia
| | - W. Stevenson
- Department of Haematology and Transfusion Medicine; Royal North Shore Hospital; Sydney New South Wales Australia
| | - D. Ritchie
- Clinical Haematology and BMT Service; Royal Melbourne Hospital; Melbourne Victoria Australia
| | - R. Bird
- Princess Alexandra Hospital; Brisbane Queensland Australia
- School of Medicine; Griffith University; Brisbane Queensland Australia
| | - L. C. Dunlop
- Haematology Department; Liverpool Hospital; Sydney New South Wales Australia
- School of Medicine; Western Sydney University; Sydney New South Wales Australia
| | - S. Durrant
- Department of Bone Marrow Transplant and Clinical Haematology; Royal Brisbane Hospital; Brisbane Queensland Australia
| | - D. M. Ross
- Haematology Directorate; SA Pathology; Adelaide South Australia Australia
| |
Collapse
|
39
|
Martinez Huenchullan S, Power J, Yee C, Morsch M, McLennan S, Twigg S, Tam C. Assessment of neuro-muscular function tests in mouse models of obesity and diabetes. J Neurol Sci 2015. [DOI: 10.1016/j.jns.2015.08.701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
40
|
Tam C, Freisthler B. An Exploratory Analysis of Linguistic Acculturation, Neighborhood, and Risk Behaviors among Children of Southeast Asian Immigrants. Child Adolesc Social Work J 2015; 32:383-393. [PMID: 26740736 PMCID: PMC4698827 DOI: 10.1007/s10560-014-0372-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Affiliation(s)
| | - Bridget Freisthler
- Associate Professor Department of Social Welfare, University of California, Los Angeles, (310) 206-1602, f: (310) 206-7564
| |
Collapse
|
41
|
Saulep-Easton D, Vincent FB, Quah PS, Wei A, Ting SB, Croce CM, Tam C, Mackay F. The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia 2015; 30:163-72. [PMID: 26139429 PMCID: PMC4606984 DOI: 10.1038/leu.2015.174] [Citation(s) in RCA: 56] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2014] [Revised: 04/28/2015] [Accepted: 06/16/2015] [Indexed: 12/11/2022]
Abstract
Interleukin (IL)-10-producing B cells (B10 cells) have emerged as important regulatory players with immunosuppressive roles. Chronic lymphocytic leukemia (CLL) B cells also secrete IL-10 and share features of B10 cells, suggesting a possible contribution of CLL B cells to immunosuppression in CLL patients. Factors controlling the emergence of B10 cells are not known. B cell-activating factor of the tumour necrosis factor (TNF) family (BAFF) is critical for B cell maturation and survival, and is implicated in the development and progression of CLL. We sought to investigate the role of BAFF in the emergence of IL-10-producing B regulatory cells in healthy donors and CLL patients. Here, we report that BAFF signaling promotes IL-10 production by CLL B cells in a mouse model of CLL and in CLL patients. Moreover, BAFF-mediated IL-10 production by normal and CLL B cells is mediated via its receptor TACI. Our work uncovered a major targetable pathway important for the generation of regulatory B cells that is detrimental to immunity in CLL.
Collapse
Affiliation(s)
- D Saulep-Easton
- Department of Immunology, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia
| | - F B Vincent
- Department of Immunology, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia
| | - P S Quah
- Department of Immunology, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia
| | - A Wei
- Department of Haematology, The Alfred Hospital, Melbourne, Victoria, Australia.,Australian Centre for Blood Diseases, Division of Blood Cancers, Department of Medicine, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia
| | - S B Ting
- Department of Haematology, The Alfred Hospital, Melbourne, Victoria, Australia.,Australian Centre for Blood Diseases, Division of Blood Cancers, Department of Medicine, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia
| | - C M Croce
- Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, Ohio, USA
| | - C Tam
- Department of Haematology, Peter MacCallum Cancer Centre, St. Andrews's Place, East Melbourne, Victoria, Australia
| | - F Mackay
- Department of Immunology, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), Melbourne, Victoria, Australia
| |
Collapse
|
42
|
Castro‐Gomes T, Corrotte M, Tam C, Andrews N. Plasma‐membrane Repair is Regulated Extracellularly by Proteases Released from Lysosomes. FASEB J 2015. [DOI: 10.1096/fasebj.29.1_supplement.884.42] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Thiago Castro‐Gomes
- Department of Cell Biology and Molecular Genetics University of MarylandCollege ParkMarylandUnited States
| | - Matthias Corrotte
- Department of Cell Biology and Molecular Genetics University of MarylandCollege ParkMarylandUnited States
| | - Christina Tam
- Department of Cell Biology and Molecular Genetics University of MarylandCollege ParkMarylandUnited States
| | - Norma Andrews
- Department of Cell Biology and Molecular Genetics University of MarylandCollege ParkMarylandUnited States
| |
Collapse
|
43
|
Fernandes MC, Corrotte M, Miguel DC, Tam C, Andrews NW. The exocyst is required for trypanosome invasion and the repair of mechanical plasma membrane wounds. J Cell Sci 2014; 128:27-32. [PMID: 25380822 DOI: 10.1242/jcs.150573] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
The process of host cell invasion by Trypanosoma cruzi shares mechanistic elements with plasma membrane injury and repair. Both processes require Ca(2+)-triggered exocytosis of lysosomes, exocytosis of acid sphingomyelinase and formation of ceramide-enriched endocytic compartments. T. cruzi invades at peripheral sites, suggesting a need for spatial regulation of membrane traffic. Here, we show that Exo70 and Sec8 (also known as EXOC7 and EXOC4, respectively), components of the exocyst complex, accumulate in nascent T. cruzi vacuoles and at sites of mechanical wounding. Exo70 or Sec8 depletion inhibits T. cruzi invasion and Ca(2+)-dependent resealing of mechanical wounds, but does not affect the repair of smaller lesions caused by pore-forming toxins. Thus, T. cruzi invasion and mechanical lesion repair share a unique requirement for the exocyst, consistent with a dependence on targeted membrane delivery.
Collapse
Affiliation(s)
- Maria Cecilia Fernandes
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742-5815, USA
| | - Matthias Corrotte
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742-5815, USA
| | - Danilo C Miguel
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742-5815, USA
| | - Christina Tam
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742-5815, USA
| | - Norma W Andrews
- Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742-5815, USA
| |
Collapse
|
44
|
Easton D, Vincent F, Le Page M, Wei A, Ting S, Croce C, Tam C, Mackay F. S-15. Cytokine 2014. [DOI: 10.1016/j.cyto.2014.07.235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
45
|
Miller H, Tam C, Corrotte M, Castro-Gomes T, Andrews N, Song W. Mechanism of B cell membrane repair and the effects of repair on B cell receptor activation (IRC3P.460). The Journal of Immunology 2014. [DOI: 10.4049/jimmunol.192.supp.59.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Abstract
The plasma membrane of B cells is at risk for injury by bacterial toxins, viruses, and possible mechanical damage induced by interactions with other cells during antigen presentation. Whether and how B cells repair membrane damage and its impact on B-cell functions are unknown. Here we show that upon injury by the pore forming toxin streptolysin O (SLO), primary mouse splenic B cells can repair their membrane in a Ca2+-dependent manner, like muscle and epithelial cells. B cells exocytose their lysosomes in response to Ca2+ influx and release acid sphingomyelinase from lysosomes, which induces endocytosis. In B cells activated by cross-linking B-cell receptors (BCRs), repairing membrane damage by SLO inhibits BCR clustering and internalization, consequently reducing BCR-induced tyrosine phosphorylation. Further analyses show that membrane repair inhibits the colocalization of BCRs with lipid rafts on the cell surface and during their internalization, indicating that membrane repair-induced endocytosis competes with BCRs for lipid rafts and interferes with the interaction of BCRs with lipid raft-associated kinases. Our results reveal the ability and the mechanism for B cells to repair membrane damage, and discover a negative regulatory role of membrane repair on B cell signaling and antigen uptake functions.
Collapse
|
46
|
Saulep-Easton D, Vincent FB, Le Page M, Wei A, Ting SB, Croce CM, Tam C, Mackay F. Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia. Leukemia 2014; 28:2005-15. [PMID: 24721775 PMCID: PMC4100939 DOI: 10.1038/leu.2014.105] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2013] [Revised: 02/10/2014] [Accepted: 03/06/2014] [Indexed: 02/06/2023]
Abstract
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD5+CD19+ B cells in the peripheral blood, and in primary and secondary lymphoid organs. A major complication associated with CLL is severe recurrent infections, which are often fatal. Vulnerability to infection is due to a wide variety of immunological defects, yet the initiating events of immunodeficiency in CLL are unclear. Using CLL patient samples and a mouse model of CLL, we have discovered that plasmacytoid dendritic cells (pDCs), which underpin the activity of effector immune cells critical for anti-viral immunity and anti-tumor responses, are reduced in number and functionally impaired in progressive CLL. As a result, the levels of interferon alpha (IFNα) production, a cytokine critical for immunity, are markedly reduced. Lower pDC numbers with impaired IFNα production was due to the decreased expression of FMS-like tyrosine kinase 3 receptor (Flt3) and Toll-like receptor 9 (TLR9), respectively. Reduced Flt3 expression was reversed using inhibitors of TGF-β and TNF, an effect correlating with a reduction in tumor load. Defects in pDC numbers and function offer a new insight into mechanisms underpinning the profound immunodeficiency affecting CLL patients and provide a potentially novel avenue for restoring immuno-competency in CLL.
Collapse
Affiliation(s)
- D Saulep-Easton
- Department of Immunology, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), 89 Commercial Road, Melbourne, Victoria, Australia
| | - F B Vincent
- Department of Immunology, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), 89 Commercial Road, Melbourne, Victoria, Australia
| | - M Le Page
- Department of Immunology, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), 89 Commercial Road, Melbourne, Victoria, Australia
| | - A Wei
- 1] Department of Haematology, The Alfred Hospital, 55 Commercial Road, Melbourne, Victoria, Australia [2] Australian Centre for Blood Diseases, Division of Blood Cancers, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), 89 Commercial Road, Melbourne, Victoria, Australia
| | - S B Ting
- 1] Department of Haematology, The Alfred Hospital, 55 Commercial Road, Melbourne, Victoria, Australia [2] Australian Centre for Blood Diseases, Division of Blood Cancers, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), 89 Commercial Road, Melbourne, Victoria, Australia
| | - C M Croce
- Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, 460 West 12th Avenue, Columbus, OH, USA
| | - C Tam
- Department of Haematology, Peter MacCallum Cancer Centre, St. Andrews's Place, East Melbourne, Victoria, Australia
| | - F Mackay
- Department of Immunology, Monash University Central Clinical School, Alfred Medical Research and Education Precinct (AMREP), 89 Commercial Road, Melbourne, Victoria, Australia
| |
Collapse
|
47
|
Corrotte M, Almeida PE, Tam C, Castro-Gomes T, Fernandes MC, Millis BA, Cortez M, Miller H, Song W, Maugel TK, Andrews NW. Caveolae internalization repairs wounded cells and muscle fibers. eLife 2013; 2:e00926. [PMID: 24052812 PMCID: PMC3776555 DOI: 10.7554/elife.00926] [Citation(s) in RCA: 113] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2013] [Accepted: 08/05/2013] [Indexed: 12/28/2022] Open
Abstract
Rapid repair of plasma membrane wounds is critical for cellular survival. Muscle fibers are particularly susceptible to injury, and defective sarcolemma resealing causes muscular dystrophy. Caveolae accumulate in dystrophic muscle fibers and caveolin and cavin mutations cause muscle pathology, but the underlying mechanism is unknown. Here we show that muscle fibers and other cell types repair membrane wounds by a mechanism involving Ca2+-triggered exocytosis of lysosomes, release of acid sphingomyelinase, and rapid lesion removal by caveolar endocytosis. Wounding or exposure to sphingomyelinase triggered endocytosis and intracellular accumulation of caveolar vesicles, which gradually merged into larger compartments. The pore-forming toxin SLO was directly visualized entering cells within caveolar vesicles, and depletion of caveolin inhibited plasma membrane resealing. Our findings directly link lesion removal by caveolar endocytosis to the maintenance of plasma membrane and muscle fiber integrity, providing a mechanistic explanation for the muscle pathology associated with mutations in caveolae proteins. DOI:http://dx.doi.org/10.7554/eLife.00926.001 Cells must be able to rapidly repair damage to their outer membranes. This is particularly important in the case of muscle cells, which are vulnerable to damage, and the failure of these cells to repair their outer membranes leads to the muscle wastage seen in muscular dystrophy. Researchers do not fully understand how cells repair membrane, but one popular theory is that they use the membranes of specialized vesicles to ‘patch’ areas that have been damaged. A group of proteins called caveolins have also been implicated in membrane repair but, again, the details have not been worked out. These proteins are best known for their role in the formation of caveolae — small pouches formed by invaginated sections of the plasma membrane. Now, Corrotte et al. have obtained evidence that membrane repair relies not on patching, but on endocytosis (the process by which substances are taken into the cell in small vesicles that ‘pinch’ from the plasma membrane) of these caveolae pouches. Corrotte et al. treated cells with streptolysin O, a toxin that forms pores in the membrane that cannot be repaired using patches, and found that this led to the formation of small membrane-derived vesicles that looked just like caveolae. Further tests confirmed that these vesicles contained caveolar proteins, and that they removed the toxin from the plasma membrane by endocytosis. Similar effects were seen in response to mechanical damage caused by tiny glass beads. Moreover, blocking the expression of caveolar genes prevented cells from repairing membrane damage. Based on their findings, Corrotte et al. propose an alternative model for the repair process; namely that cellular damage triggers an influx of calcium ions, which causes vesicles called lysosomes to release chemicals that promote the formation of caveolae. These then remove the damaged area through endocytosis, restoring the integrity of the membrane. The results offer new insights into why mutations in caveolar proteins are associated with muscle disorders, including muscular dystrophy and cardiac dysfunction. DOI:http://dx.doi.org/10.7554/eLife.00926.002
Collapse
Affiliation(s)
- Matthias Corrotte
- Department of Cell Biology and Molecular Genetics , University of Maryland , College Park , United States
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Chattaway MA, Harris R, Jenkins C, Tam C, Coia JE, Gray J, Iturriza-Gomara M, Wain J. Investigating the link between the presence of enteroaggregative Escherichia coli and infectious intestinal disease in the United Kingdom, 1993 to 1996 and 2008 to 2009. ACTA ACUST UNITED AC 2013; 18. [PMID: 24079400 DOI: 10.2807/1560-7917.es2013.18.37.20582] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
There are an estimated 17 million human diarrhoea cases annually in the United Kingdom. In 2008 and 2009, enteroaggregative E. coli (EAEC) were identified in 1.9% of stools. However, it remains unclear whether there is a causal link between presence of EAEC and disease. This study used bacterial load, the presence of co-infections and demographic data to assess if EAEC was independently associated with intestinal infectious disease. Quantitative real-time PCR data (Ct values) generated directly from stool specimens for several pathogen targets were analysed to identify multiple pathogens, including EAEC, in the stools of cases and healthy controls. Sensitivity and specificity using Ct value (60% and 60%) was not useful for identifying cases or controls, but an independent association between disease and EAEC presence was demonstrated: multivariate logistic regression for EAEC presence (odds ratio: 2.41; 95% confidence interval: 1.78–3.26; p<0.001). The population-attributable fraction was 3.3%. The group of bacteria known as EAEC are associated with gastrointestinal disease in at least half of the cases with EAEC positive stools. We conclude that the current definition of EAEC, by plasmid gene detection, includes true pathogens as well as non-pathogenic variants.
Collapse
Affiliation(s)
- M A Chattaway
- Gastrointestinal Bacteria Reference Unit, Public Health England, Colindale, London, United Kingdom
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Crosbie J, Arnold P, Paterson A, Swanson J, Dupuis A, Li X, Shan J, Goodale T, Tam C, Strug LJ, Schachar RJ. Response inhibition and ADHD traits: correlates and heritability in a community sample. J Abnorm Child Psychol 2013; 41:497-507. [PMID: 23315233 PMCID: PMC3600128 DOI: 10.1007/s10802-012-9693-9] [Citation(s) in RCA: 137] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Endophenotypes or intermediate phenotypes are of great interest in neuropsychiatric genetics because of their potential for facilitating gene discovery. We evaluated response inhibition, latency and variability measures derived from the stop task as endophenotypes of ADHD by testing whether they were related to ADHD traits in the general population, heritable and shared genetic risk with ADHD traits. Participants were 16,099 children and adolescents, ages 6 to 18 years who visited a local science center. We measured ADHD traits using the Strengths and Weaknesses of ADHD-symptoms and Normal-Behavior (SWAN) rating scale and performance on the stop signal task (SST)-response inhibition (SSRT), response latency (GoRT), and response variability (GoRTSD). Regression analysis was used to assess the relationship of cognitive measures and ADHD traits while controlling for family, age, sex, ethnicity, socioeconomic status and treatment status. Heritability of ADHD and cognitive traits was estimated using SOLAR in 7,483 siblings from 3,507 families that included multiple siblings. Bivariate relationships between pairs of variables were examined. Individuals with greater ADHD trait scores had worse response inhibition, slower response latency, and greater variability. Younger participants and girls had inferior performance although the gender effects were minimal and evident in youngest participants. Inhibition, latency, variability, total ADHD traits, inattention and hyperactivity-impulsivity scores were significantly heritable. ADHD traits and inhibition, but not latency or variability were coheritable. In the largest study in the general population, we found support for the validity of response inhibition as an endophenotype of ADHD.
Collapse
Affiliation(s)
- J. Crosbie
- Neurosciences and Mental Health Program, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
- Department of Psychiatry, Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON Canada M5G 1X8
| | - P. Arnold
- Genetics and Genomic Biology Program, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
- Department of Psychiatry, Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON Canada M5G 1X8
| | - A. Paterson
- Genetics and Genomic Biology Program, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - J. Swanson
- Department of Pediatrics, School of Medicine, University of California Irvine, Irvine, CA USA
- Department of Psychiatry, Florida International University, University Park, FL USA
- Sackler Institute, Department of Psychiatry, Weill College of Medicine at Cornell University, Ithaca, NY USA
| | - A. Dupuis
- Research Operations, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
- Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - X. Li
- Genetics and Genomic Biology Program, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
- Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - J. Shan
- Neurosciences and Mental Health Program, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - T. Goodale
- Neurosciences and Mental Health Program, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - C. Tam
- Genetics and Genomic Biology Program, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - L. J. Strug
- Research Operations, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
- Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - R. J. Schachar
- Neurosciences and Mental Health Program, Research Institute, The Hospital for Sick Children, University of Toronto, Toronto, Canada
- Department of Psychiatry, Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON Canada M5G 1X8
| |
Collapse
|
50
|
Ho J, Wu A, Tsang S, Lee P, Lee M, Lau S, Kwok S, Kwan R, Lam P, Chan W, Lam C, Tam C, Lee S, Lui T, Lee N, Li M, Lo W, Lau W. PP159-SUN NUTRITIONAL STATUS PREDICTS SURGICAL OUTCOME IN PATIENTS UNDERGOING GASTROINTESTINAL OPERATIONS: RESULTS OF A PROSPECTIVE STUDY. Clin Nutr 2013. [DOI: 10.1016/s0261-5614(13)60204-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|